Program

09:00 – 09:30: Welcome of participants

09:30 – 09:40: Introduction

09:40 – 10:40: Technological and methodological innovations from NeurATRIS

09:40 – 10:00: Towards quantitative and ultrastructural imaging (Xavier Heiligenstein, Chief Scientific Officer de CryoCapCell, M. Schumacher and C. Specht, Inserm U1195, Le Kremlin Bicêtre)

10:00 – 10:20: New models of synucleinopathies (R. Aron Badin and A. Perrier, CEA MIRcen, Fontenay-aux-Roses)

10:20 – 10:40: Automated language analysis in neurodegenerative diseases (C. Lemoine, Inserm U955, Mondor Institute for Biomedical Research, Créteil)

10:40 – 11:15: Coffee break

11:15 – 12:15: Spotlight on key NeurATRIS platforms

11:15 – 11:30: Nikon Nantes Center of Excellence: “Improved access to innovative two-photon microscopy” (UMR 703 PAnTher, INRAE/Oniris)

11:30 – 11:45: Neuroinflammation platform of NeuroDiderot (J. Van Steenwinckel, Inserm U1141, Robert Debré Hospital, Paris).

11:45 – 12:00: Spatial transcriptomics platform of ICM (Brain Institute, Paris)

12:00 – 12:15: PET imaging platform at CEA-MIRcen (O. Barret, CEA MIRcen, Fontenay-aux-Roses)

12:15 – 12:30: EU Tracer Factory Project: Development and production of radiotracers (S. Zullino, EATRIS, Amsterdam; N. Van Camp, CEA MIRcen, Fontenay-aux-Roses)

12:30 – 14:00: Cocktail lunch

14:00 – 14:10: Student testimonials

14:10 – 15:25: Translational developments from NeurATRIS

14:10 – 14:30: Mesenchymal stem cells and neuroprotection in the premature brain (P. Gressens, NeuroDiderot Inserm U1141, Robert Debré Hospital, Paris)

14:30 – 14:50: Gene therapy for X-ALD (P. Bougnères, Therapy Design Consulting)

14:50 – 15:10: Electrical activity to promote remyelination in multiple sclerosis: results from translational ON-STIM trial (C. Louapre, Paris Brain Institute)

15:10 – 15:25: Identification of Proteomic Markers in Plasma for Cognitive Decline in Parkinson’s Disease (R. Louiset, Inserm U955, Mondor Institute for Biomedical Research, Créteil)

15:25 – 15:30: Conclusion
End of the day for all participants except for the supervisory bodies and members of the NeurATRIS Scientific Advisory Board  and COMEX.

16:00 – 16:45: Deliberation of the Scientific Advisory Board

16:00 – 18:00: Closing meeting with representatives from MESR, ANR, supervisory authorities, COMEX, and the Scientific Advisory Board of NeurATRIS